Resources Contact Us Home
Modified factor VIII

Image Number 8 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Flow cytometer method and apparatus
Circuit breakers
Compounds, compositions and methods for reducing lipid levels
Home appreciation participation notes
Multiplexing channels by a medium access controller
Catecholic butanes and use thereof for cancer therapy
Fabrication of thin pellicle beam splitters
  Randomly Featured Patents
Window component extrusion
Wind power installation with contactless power transmitter
Optimal methodology for allocation and flowdown
Stable mitoxantrone solutions
Phase shift modulation-based control of amplitude of AC voltage output produced by double-ended DC-AC converter circuitry for powering high voltage load such as cold cathode fluorescent lamp
Method and apparatus for automatic configuration of multiple on-chip interconnects
Tire tread and buttress
Casting system having lubricated casting nozzles
Elevating platform system